Pharmaxis hopeful of FDA approval for cystic fibrosis inhalation medicine Bronchitol by Q1 2020
Pharmaxis Ltd (ASX:PXS) chief executive officer Gary Phillips updates Proactive Investors on the FDA approval timeframe for the company’s...
Gene Editing Tool Corrects CF-causing Mutations in Patient-derived Cells, Study Shows
Using the CRISPR gene editing tool, a team of researchers was able to permanently correct two mutations in the CFTR gene — mutations that...
Powerful weapon discovered to fight antibiotic resistance in Staphylococcus aureus
Staphylococcus aureus bacteria are a major cause of serious infections that often persist despite antibiotic treatment, but scientists at...
Lung damage bacteria sniffed out by dogs in cystic fibrosis research
A new study found the animals can detect ultra-low concentrations of pseudomonas, the commonest cause of lung infection in the disease....
Different CFTR Potentiators Bind to Same Flexible Spot on Protein, Study Finds
Approved and investigative cystic fibrosis (CF) treatments known as CFTR potentiators work by binding to the same flexible protein spot —...
Specific Variables Improve Disease Severity Discrimination Among CF Transplant Candidates
The inclusion of Cystic Fibrosis Foundation Patient Registry variables in the lung allocation score (LAS) calculation allowed for...
Babies Treated with Synagis Show No Lasting Benefits in Lung Health as 7-Year-Olds, Real-world Study
Treating infants with cystic fibrosis (CF) with the antiviral therapy Synagis(palivizumab) does not improve long-term outcomes in lung...
Organoids grown in microfluidic device may help cf patients with diabetes
Scientists created human pancreas on a chip that allowed them to identify the possible cause of a frequent and deadly complication of...
Modified and More Rigorous Cleansing Procedure May Better Prepare CF Patients for Colonoscopy, Study
People with cystic fibrosis (CF) may require a modified and more rigorous cleansing procedure to prepare their bowels for a colonoscopy...
Hinge-like protein may open new doors in cystic fibrosis treatment
In recent decades, treatment options for people with cystic fibrosis have improved dramatically. The newest drugs, known as potentiators,...
